Virtus Biotech Clinical Trials ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.79
資產淨值: 42.98
成立日期: 16/12/2014
 
分析
市值分佈:
23.20%
大市值
44.62%
中市值
28.08%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 124  
0%
 
100%
     10大 (14.75%)
代號 名稱 佔比% 持有日期
CGEMCullinan Therapeutics0.9627/02/2026
RVMDRevolution Medicines0.9527/02/2026
EWTXEdgewise Therapeutics0.9527/02/2026
CTMXCytomX Therapeutics0.9527/02/2026
SYRESpyre Therapeutics0.9427/02/2026
RLAYRelay Therapeutics0.9427/02/2026
NKTRNektar Therapeutics0.9327/02/2026
PRAXPraxis Precision Medicines0.9227/02/2026
ANABAnaptysBio0.9027/02/2026
ENGNenGene Holdings0.8827/02/2026
TNGXTango Therapeutics0.8827/02/2026
OMEROmeros Corp0.8827/02/2026
TECXTectonic Therapeutic Inc.0.8727/02/2026
MLTXMoonLake Immunotherapeutics0.8727/02/2026
DNLIDenali Therapeutics0.8727/02/2026
MAZEMaze Therapeutics Inc0.8727/02/2026
AMLXAmylyx Pharmaceuticals0.8527/02/2026
SEPNSepterna Inc0.8427/02/2026
ORKAOruka Therapeutics Inc0.8427/02/2026
GHRSGH Research PLC0.8427/02/2026
  1   2    3    4    5    6    7  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.